logo
How a respiratory virus could trigger heart failure: What you should know about HMPV

How a respiratory virus could trigger heart failure: What you should know about HMPV

Sinar Daily20-05-2025
OFTEN mistaken for the common cold, Human Metapneumovirus (HMPV) is gaining attention from cardiologists for its hidden danger — especially to those with pre-existing heart conditions. Sri Kota Specialist Medical Centre Consultant Cardiologist and Physician Dr. G.S. Sridhar explains how this respiratory virus can quietly strain the cardiovascular system and even trigger life-threatening complications in vulnerable individuals.
Human Metapneumovirus (HMPV) is a respiratory virus known to cause both upper and lower respiratory tract infections. While it usually results in mild cold-like symptoms in healthy adults, the virus poses a more serious risk to high-risk groups such as the elderly, young children, and individuals with chronic health issues — particularly those with cardiovascular disease.
'Respiratory infections can reduce oxygen levels, increase inflammation, and strain the cardiovascular system, potentially worsening heart disease or triggering serious complications like heart failure or arrhythmias,' Dr Sridhar said.
According to the Health Ministry, Malaysia saw 327 cases of human metapneumovirus (HMPV) infections in 2024, a 45 per cent rise from the 225 cases in 2023.
HMPV is a relatively recent discovery in human respiratory viruses and, like Respiratory Syncytial Virus (RSV), can cause conditions ranging from asymptomatic infection to severe bronchiolitis. Consultant Cardiologist and Physician Dr. G.S. Sridhar explains how this respiratory virus can quietly strain the cardiovascular system and even trigger life-threatening complications in vulnerable individuals.
How The Immune System's Response Can Strain The Heart
=When someone contracts a virus like HMPV, the body responds by activating its immune defenses. This response involves the release of cytokines, proteins that initiate inflammation to help eliminate the virus. But in some cases, particularly for people with pre-existing heart conditions, the inflammation becomes excessive and places stress on the heart.
'This inflammation causes the heart to work harder, which can be risky for older adults or people with existing heart conditions like high blood pressure, heart disease, or blocked arteries,' Dr Sridhar said.
This strain intensifies during fever or tachycardia, a condition that causes irregular rapid heartbeat, where the heart's demand for oxygen increases. At the same time, the body undergoes vasoconstriction, otherwise described as the tightening of blood vessels, and fluid shifts, making it more difficult for the heart to function efficiently.
These conditions can overwhelm an already compromised cardiovascular system, increasing the risk of acute decompensation, heart failure, or other severe events.
'The same inflammation can also disturb plaque buildup in the arteries — a dangerous event that could lead to a heart attack,' he added.
Common Heart Complications From HMPV and How Quickly They Can Escalate
Although many patients recover from respiratory infections without lasting issues, Dr Sridhar cautioned that some individuals may develop serious cardiac complications — and symptoms can worsen and progress very quickly, often within just days of infection.
According to him, the most common heart-related complications following a respiratory virus like HMPV include:
"Heart failure, where the heart can't pump blood as well as it should. Arrhythmias, irregular heartbeats that can be dangerous if not treated. Finally, Myocarditis, inflammation of the heart muscle, often caused by the virus itself or the immune response to it." Dr. Sridhar stated.
Alternatively, another serious risk is acute coronary syndrome (ACS), which includes conditions like heart attacks.
A landmark study published in the New England Journal of Medicine found that patients were six times more likely to suffer a heart attack in the week following a respiratory viral infection like influenza. Though HMPV is newer to medical research, similar risks are under close investigation.
This sentiment is echoed by cardiologist Dr V. Corrales-Medina, who noted in a medical journal published in 2013:
'An infection can act as a trigger that sets off a chain reaction in the body, leading to heart problems that otherwise might not have surfaced.' HMPV is a relatively recent discovery in human respiratory viruses and, like Respiratory Syncytial Virus (RSV), can cause conditions ranging from asymptomatic infection to severe bronchiolitis. Photo: Canva
Importance of Early Detection and Awareness
Given how fast heart-related complications can appear, Dr Sridhar advised people — especially older adults and those with chronic heart disease — to take any signs of chest discomfort, shortness of breath, or unusual fatigue during or after a respiratory infection seriously.
"What makes this more concerning is how quickly symptoms can appear and worsen.
'Delaying care increases the risk of permanent heart damage or even sudden death,' he warned.
Even as HMPV continues to fly under the radar compared to viruses like Covid-19 or influenza, its potential cardiovascular effects make it a threat that should not be ignored — particularly by those already living with heart disease.
As more respiratory viruses emerge or re-emerge, the line between lung and heart health becomes increasingly blurred. The case of HMPV underlines the importance of proactive healthcare, especially for those in vulnerable groups.
In light of the concerning rise of HMPV, it is advised by many health experts such as Dr Sridhar, to go for regular health screenings, vaccination where applicable, and immediate medical attention when symptoms arise as critical strategies for protecting heart health during respiratory illness seasons.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Action against drug abuse through illegal vape products
Action against drug abuse through illegal vape products

The Sun

timean hour ago

  • The Sun

Action against drug abuse through illegal vape products

PETALING JAYA: Fifty-five cases of drug abuse involving electronic cigarettes or vapes were recorded in the first half of 2025 alone, said the Health Ministry. Citing police figures, it said a total of 64 investigation papers were opened in 2024 on the issue. 'Alarmingly, over 70% of these cases tested positive for banned substances such as amphetamines and synthetic cannabinoids,' it said in a statement. The ministry was responding to an Aug 4 report in theSun on sales through online platforms of vape liquids laced with a harmful synthetic substance known as 'Magic Mushroom'. 'The ministry takes seriously the media report published by theSun. These illegal products, reportedly available in the local market, have been linked to severe side effects such as hallucinations, loss of self-control and, in one shocking incident, a student jumping off a school building while under the influence.' The ministry reaffirmed its commitment to working closely with police to tighten surveillance and enforcement on electronic smoking products suspected of containing controlled or dangerous substances. All smoking products, including electronic cigarettes and vape devices, are regulated under the Control of Smoking Products for Public Health Act 2024 (Act 852) which came into force on Oct 1, 2024. Under Section 3 of the Act, all smoking products must be registered and have their contents declared to the ministry before they can be sold. Only products that meet health and safety requirements will be approved. The government is also stepping up safety standards for vape devices in collaboration with the Standards Department and the Standards and Industrial Research Institute of Malaysia. This includes ensuring that devices cannot be easily modified to include illicit or hazardous substances. The ministry has issued a stern warning to parents, educators and the public to remain vigilant, particularly against unregulated or illegal vape products sold online or directly to teenagers, stressing the need for early intervention. 'Immediate reporting of such products or related behaviour to the authorities can save lives. The ministry is fully committed to protecting the health and safety of Malaysians, especially the younger generation, from the threat of dangerous and unregulated smoking products.' On Aug 5, Home Minister Datuk Seri Saifuddin Nasution Ismail said the government is reviewing potential amendments to existing laws to combat the growing issue of online drug sales. theSun had reported that 'Magic Mushroom' vape liquid, laced with synthetic drugs, is being sold online for as little as RM1 per drop, making it easily accessible to youths and first-time users.

Groups call for joint crack down on online vape sales
Groups call for joint crack down on online vape sales

The Star

timean hour ago

  • The Star

Groups call for joint crack down on online vape sales

PETALING JAYA: A well-coordinated and joint effort among the relevant authorities is needed to effectively crack down against online vape sales, say anti-tobacco advocates. This comes as vapes and e-liquids are still being sold openly online, despite their prohibition under the Control of Smoking Products for Public Health Act (Act 852). Malaysian Council for Tobacco Control president Assoc Prof Dr M. Murallitharan said tackling the issue could not solely rest with the Health Ministry. 'The Malaysian Communica­tions and Multimedia Commission and other related authorities must take a strong policing stance. 'It is not a single agency or ministry's issue. 'The Health Ministry can take the lead, but the other authorities must come on board,' he said. 'It is a joke that these products can be found so easily, and that the issue cannot be resolved,' he said. 'Any quarters found doing this should be taken to task,' he said. Without any strict policing efforts, he said Act 852 would remain just for optics. Consumers Association of Penang (CAP) senior education officer NV Subbarow said both the Health Ministry and MCMC must work together to eradicate online sales of vapes and e-liquids. 'If MCMC can take immediate action against provocative statements online, why can't it take action against online vape sellers?' he said. 'Our government must be very serious in tackling this. There must be no excuses.' He said a lack of enforcement could expose children to more harmful substances in the future. Meanwhile, vape groups also voiced support for the ban on online vape sales. 'We are completely against this (online sales) as it makes the product accessible to minors. These websites don't have any age verification,' said Malaysian Organisation of Vape Entities president Samsul Kamal Arrifin. He urged MCMC to block access to websites selling vape products and for authorities to ensure the location of premises applying to sell vapes are not near schools or easily accessible to schoolchildren. Samsul Kamal also called on the Health Ministry to ensure the products are only sold in specialised vape shops and not convenience stores. 'The former have trained staff who can verify the age of buyers,' he said. According to Malaysia E-Vapor-isers and Tobacco Alternative Association secretary Zain Azrul, selling vape products through independent websites is illegal and goes against regulatory goals, public health and the integrity of licensed businesses. 'All sales should go through licensed physical retail shops with proper age verification. 'Illegal online sales pose a serious risk by avoiding in-person age verification,' he said. The group also strongly supports strict enforcement measures against illegal online sales of vape products, he added.

Full enforcement of medicine price display policy begins Jan 1
Full enforcement of medicine price display policy begins Jan 1

New Straits Times

timean hour ago

  • New Straits Times

Full enforcement of medicine price display policy begins Jan 1

Your browser does not support the audio element. KUALA LUMPUR: Private healthcare centres and community pharmacy facilities must fully comply with the medicine price display policy rules starting Jan 1 next year, the Dewan Rakyat heard yesterday. Deputy Health Minister Datuk Lukanisman Awang Sauni said the move follows an enforcement education period of three months ending on July 31 where no penalty and compounds were issued. "This was then continued with the phased administrative enforcement period on Aug 1, during which inspections and monitoring will be conducted until Dec 31. "During this period, reminder letters will be issued to non-compliant facilities, while compounds for repeated offences will be imposed from Oct 1," he said. A full enforcement will be made next year. Lukanisman said this in response to Datuk Dr Ahmad Yunus Hairi (PN-Kuala Langat), who questioned the status of the implementation phase of the medicine price display regulation and its effectiveness in curbing hidden healthcare costs. He added that as of July 31, 55 per cent (900 out of 1,639 inspected facilities) had satisfactorily complied with the requirements. "However, 45 per cent, or 739 facilities, had yet to meet the expected compliance level, including having incomplete price displays or displays that were not easily accessible. "These findings indicate the need for stricter monitoring, guidance sessions, and phased enforcement against non-compliant premises," he said. The Health Ministry will also conduct the Medicine Prices Monitoring Study, starting next month, to evaluate the policy's impact to improve pricing transparency. The aim, he said, was to create a more transparent, fair and consumer-friendly private healthcare system. The mandatory price labelling for medicines at private healthcare centres and community pharmacy facilities was rolled out on May 1.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store